亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

TiDEC

总结: a DNA-encoded substance library for drug screening with a novel encoding approach that allows previously unfeasible chemical reactions that massively broadens the diversity of producible molecules.

技术优势: Handling of large encoded compound screening libraries: tiDELs
Access to biologically relevant chemical space that is inaccessible by conventional DNA-encoded libraries: encoded natural product- and drug-derived compound classes
Efficient and rapid screening on target proteins by selection
Extremely reduced costs in comparison to conventional high-throughput screening
Accelerated identification of starting points for drug development programs

技术应用: The TIDEC platform technology and the tiDEL screening library are offered to pharma-companies, biotech companies, and non-profit organizations for drug identification and development programs.

详细技术说明: TiDEC addresses this severe
limitation. TiDEC exploits the stability
of oligopyrimidine adapter sequences
to a large variety of reaction
conditions, and reagents such as
transition metal catalysts and acidic
organocatalysts. Thus, TiDEC
enables efficient access to diverse
heterocyclic structures conjugated to
oligopyrimidine sequences from
simple and readily available starting
materials by a large variety of
catalysts. These oligonucleotideheterocycle
conjugates are readily
ligated to coding DNA sequences.

欲了解更多信息，请点击这里